Breaking News Instant updates and real-time market news.

NVCR

Novocure

$21.50

-0.1 (-0.46%)

18:27
09/24/17
09/24
18:27
09/24/17
18:27

Combination of Novocure Optune with Temozolomide demonstrates five-year survival

Novocure announced today results from its phase 3 pivotal EF-14 trial adding Optune to temozolomide for the treatment of newly diagnosed glioblastoma, or GBM, including results from health-related quality of life analyses, were presented at the American Society for Radiation Oncology's 2017 Annual Meeting in San Diego. Novocure's EF-14 phase 3 pivotal trial demonstrated "unprecedented" five-year survival results in newly diagnosed GBM. Patients treated with Optune in combination with temozolomide experienced a significant extension of overall survival without added toxicity compared to patients treated with temozolomide alone. The data also showed that Optune-treated patients were able to maintain quality of life for longer compared to patients treated with temozolomide alone. The EF-14 data showed median overall survival was extended by nearly five months for patients who received Optune in combination with temozolomide versus patients who received temozolomide alone. When measured annually for five consecutive years, patients treated with Optune in combination with temozolomide maintained superior rates of survival in newly diagnosed GBM versus patients treated with temozolomide alone. The five-year survival rate was 13% for patients treated with Optune together with temozolomide versus five percent for patients treated with temozolomide alone. The EF-14 data also showed that Optune with temozolomide did not negatively impact health-related quality of life, except for itchy skin. The combination treatment of Optune with temozolomide improved deterioration-free survival of several predefined health-related quality of life scales, compared to treatment with temozolomide alone.

NVCR Novocure
$21.50

-0.1 (-0.46%)

05/24/17
WELS
05/24/17
UPGRADE
Target $15
WELS
Outperform
Novocure upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Larry Biegelsen upgraded Novocure to Outperform and raised his price target for the shares to $15 from $11.50. Feedback from consultants suggest that physician impression of Optune may be improving, Biegelsen tells investors in a research note. The consultants believe that the 5-year safety/efficacy results from EF-14 trial, which showed continued survival benefit, is "meaningful and would be hard to ignore," even for doctors previously skeptical of Optune for treating glioblastoma, the analyst adds.
07/12/17
WEDB
07/12/17
NO CHANGE
WEDB
Novocure removed from Best Ideas List at Wedbush
Wedbush removed Novocure from its Best Ideas List based on valuation.
07/28/17
WEDB
07/28/17
NO CHANGE
WEDB
Outperform
Novocure should be bought on post-earnings pullback, says Wedbush
Wedbush analyst Tao Levy attributes the post-earnings pullback in Novocure to confusion regarding the comparison of the company's reported revenue to the published consensus estimate, but he does not believe it is an "apples-to-apples" comparison. Levy, who said that Optune prescriptions and active patients are "significantly" ahead of expectations, recommends buying the stock on the confusion and keeps an Outperform rating on the shares, which are down 1% in early trading.
09/06/17
MZHO
09/06/17
INITIATION
Target $25
MZHO
Buy
Novocure initiated with a Buy at Mizuho
Mizuho initiated Novocure with a Buy and a $25 price target.

TODAY'S FREE FLY STORIES

SPB

Spectrum Brands

$101.13

-0.77 (-0.76%)

13:45
02/21/18
02/21
13:45
02/21/18
13:45
Options
Spectrum Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 07

    Mar

13:45
02/21/18
02/21
13:45
02/21/18
13:45
General news
Breaking General news story  »

FOMC Minutes to be…

IART

Integra LifeSciences

$51.63

-0.63 (-1.21%)

13:43
02/21/18
02/21
13:43
02/21/18
13:43
Hot Stocks
Breaking Hot Stocks news story on Integra LifeSciences »

Champlain Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Mar

NCI

Navigant Consulting

$21.66

2.92 (15.58%)

13:43
02/21/18
02/21
13:43
02/21/18
13:43
Downgrade
Navigant Consulting rating change  »

Navigant Consulting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCI

Navigant Consulting

$21.68

2.94 (15.69%)

13:40
02/21/18
02/21
13:40
02/21/18
13:40
Downgrade
Navigant Consulting rating change  »

Navigant Consulting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$33.74

0.9 (2.74%)

13:38
02/21/18
02/21
13:38
02/21/18
13:38
Hot Stocks
Twitter: TweetDeck to no longer allow concurrent actions from multiple accounts »

Twitter's Yoel Roth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

MO

Altria Group

$64.06

-0.13 (-0.20%)

13:37
02/21/18
02/21
13:37
02/21/18
13:37
Hot Stocks
Altria Group plans to reinvest one-third of tax reform benefit in 2018 »

CFO Billy Gifford says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SO

Southern Company

$43.25

-0.225 (-0.52%)

13:35
02/21/18
02/21
13:35
02/21/18
13:35
Hot Stocks
Breaking Hot Stocks news story on Southern Company »

Southern Company says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

QCOM

Qualcomm

$63.99

-0.86 (-1.33%)

, AVGO

Broadcom

$249.62

0.73 (0.29%)

13:35
02/21/18
02/21
13:35
02/21/18
13:35
Recommendations
Qualcomm, Broadcom analyst commentary  »

Stifel sees Broadcom…

QCOM

Qualcomm

$63.99

-0.86 (-1.33%)

AVGO

Broadcom

$249.62

0.73 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

MO

Altria Group

$64.11

-0.08 (-0.12%)

13:25
02/21/18
02/21
13:25
02/21/18
13:25
Hot Stocks
Altria Group says focused on stabilizing Marlboro share »

COO Howard Willard says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BA

Boeing

$358.54

5.19 (1.47%)

13:25
02/21/18
02/21
13:25
02/21/18
13:25
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing says additive and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

UNIT

Uniti Group

$15.44

-0.69 (-4.28%)

13:25
02/21/18
02/21
13:25
02/21/18
13:25
Options
Uniti Group call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 05

    Mar

TROW

T. Rowe Price

$109.91

-0.58 (-0.52%)

13:25
02/21/18
02/21
13:25
02/21/18
13:25
Conference/Events
T. Rowe Price to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Apr

BA

Boeing

$358.70

5.3515 (1.51%)

13:22
02/21/18
02/21
13:22
02/21/18
13:22
Hot Stocks
Boeing says737 MAX production line ramping up to 47 per month »

The company will get up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

SO

Southern Company

$43.39

-0.08 (-0.18%)

13:22
02/21/18
02/21
13:22
02/21/18
13:22
Hot Stocks
Breaking Hot Stocks news story on Southern Company »

Southern Company sees 8c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SO

Southern Company

$43.43

-0.04 (-0.09%)

13:21
02/21/18
02/21
13:21
02/21/18
13:21
Hot Stocks
Breaking Hot Stocks news story on Southern Company »

Southern Company says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

13:20
02/21/18
02/21
13:20
02/21/18
13:20
General news
Treasury Action: yields remained relatively inert »

Treasury Action: yields…

WMT

Walmart

$92.00

-2.11 (-2.24%)

13:17
02/21/18
02/21
13:17
02/21/18
13:17
Technical Analysis
Technical Take: Walmart moves up off lows of the day »

The shares are down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

$NSD

NASDAQ Market Internals

13:17
02/21/18
02/21
13:17
02/21/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$27.68

1.24 (4.69%)

, GE

General Electric

$14.53

-0.21 (-1.42%)

13:16
02/21/18
02/21
13:16
02/21/18
13:16
Hot Stocks
Baker Hughes rises after GE CFO signals plans to stand pat until lockup expires »

Shares of Baker Hughes…

BHGE

Baker Hughes

$27.68

1.24 (4.69%)

GE

General Electric

$14.53

-0.21 (-1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

$NYE

NYSE Market Internals

13:16
02/21/18
02/21
13:16
02/21/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
02/21/18
02/21
13:15
02/21/18
13:15
General news
Treasury's upsized $35 B 5-year auction was ok, as expected »

Treasury's upsized…

SO

Southern Company

$43.29

-0.18 (-0.41%)

13:14
02/21/18
02/21
13:14
02/21/18
13:14
Hot Stocks
Southern Company sees productivity improvement at Vogtle »

Says will look to reduce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MO

Altria Group

$64.04

-0.15 (-0.23%)

13:11
02/21/18
02/21
13:11
02/21/18
13:11
Hot Stocks
Altria Group aspires to be U.S. leader in non-combustible, reduced-risk products »

CEO Marty Barrington says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

13:07
02/21/18
02/21
13:07
02/21/18
13:07
General news
5-Yr Note Auction Coupon Rate data reported »

5-Yr Note Auction Coupon…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.